The emerging therapy of the medication represents a significant advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects multiple pathways – GLP-1 and the GIP hormone – leading to https://tirzepatidepeptide209508.blogpixi.com/42423568/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment